Valsartan and Aplastic anemia - a phase IV clinical study of FDA data

Summary:

Aplastic anemia is reported as a side effect among people who take Valsartan (valsartan), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Movicol, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Aplastic anemia when taking Valsartan. It is created by eHealthMe based on reports of 62,763 people who have side effects when taking Valsartan from the FDA, and is updated regularly.

What is Valsartan?

Valsartan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 63,805 Valsartan users. Check the latest studies of Valsartan.

What is Aplastic anemia?

Aplastic anemia is found to be associated with 625 drugs and 879 conditions by eHealthMe. Check the latest studies of Aplastic anemia.

On Jul, 14, 2026

62,763 people reported to have side effects when taking Valsartan.
Among them, 63 people (0.1%) have Aplastic anemia.

Among these 63 people:

How long have people been on Valsartan when they have Aplastic anemia? *

What is the gender of people who have Aplastic anemia when taking Valsartan? *

female: 86.21 %
male: 13.79 %

What is the age of people who have Aplastic anemia when taking Valsartan? *

What are other drugs people take besides Valsartan? *

Humira: 46 people, 73.02%
Movicol: 46 people, 73.02%
Clopidogrel: 44 people, 69.84%
Fentanyl Transdermal System: 31 people, 49.21%
Pantoprazole: 31 people, 49.21%
Prednisolone: 12 people, 19.05%
Bisoprolol Fumarate: 12 people, 19.05%
Lactulose: 10 people, 15.87%
Sodium Chloride: 10 people, 15.87%
Simvastatin: 10 people, 15.87%

What are other side effects people have besides Aplastic anemia? *

Anaemia (lack of blood): 48 people, 76.19%
Mitral Valve Incompetence (inefficient heart valve): 47 people, 74.60%
Nausea And Vomiting: 47 people, 74.60%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 47 people, 74.60%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 47 people, 74.60%
Escherichia Infection (bacterial infection by escherichia coli): 47 people, 74.60%
Indigestion: 47 people, 74.60%
Diverticulum Intestinal (a pouch that is attached to the first part of the small intestine): 47 people, 74.60%
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased): 47 people, 74.60%
Belching (release of gas from the digestive tract): 47 people, 74.60%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 47 people, 74.60%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 45 people, 71.43%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 7.94%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 7.94%
Type 2 Diabetes: 5 people, 7.94%
Dyslipidaemia (abnormal amount of lipids): 5 people, 7.94%
Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 3.17%
Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 2 people, 3.17%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 1.59%
Cardiac Failure: 1 person, 1.59%

* Approximation only. Some reports may have incomplete information.

Do you take Valsartan and have Aplastic anemia?

- Check whether Aplastic anemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Valsartan:

Valsartan (63,805 reports)

Aplastic anemia treatments and more:

Aplastic anemia (14,870 reports)

Browse all side effects of Valsartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Aplastic anemia:

Aplastic anemia (625 drugs)

Browse all the conditions that are associated with Aplastic anemia:

Aplastic anemia (879 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on valsartan (the active ingredients of Valsartan) and Valsartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.